Skip to main content
Veterinary Medicines

HIPRADOG-DP, Injekce

Authorised
  • Canine distemper virus, strain Lederle, Live
  • Canine parvovirus, strain Cornell 780916, Live

Product identification

Medicine name:
HIPRADOG-DP, Injekce
Active substance:
  • Canine distemper virus, strain Lederle, Live
  • Canine parvovirus, strain Cornell 780916, Live
Target species:
  • Dog (puppy)
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine distemper virus, strain Lederle, Live
    5.50
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine parvovirus, strain Cornell 780916, Live
    7.50
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog (puppy)
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AD03
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/047/03-C
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."